You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《全日總結》恆指升224點 科技及醫藥股領漲 藥明生物彈逾6%
美上月通脹符預期,市場憧憬美聯儲下月初加息四分一厘,港股今日造好,恆指高開90點,早段曾跌39點一度低見21,474點,午後曾升255點一度高見21,770點,全日升224點或1%,收21,738點;國指升79點或1.1%,收7,391點;恆生科技指數67點或1.5%,收4,554點。大市全日成交總額1,330.11億元,滬、深港通南下交易淨流入17.35億及23.13億元人民幣。 科技股午後造好,騰訊(00700.HK)升2%報371.4元,市傳阿里巴巴(09988)減持印度Paytm套現1.25億美元,股價升1.7%報112.7元。美團(03690.HK)跌幅收窄至1%,京東(09618.HK)倒升0.3%報248.2元,小米(01810.HK)升1.5%報11.96元。騰訊音樂(01698.HK)獲大摩唱好,股價升3.8%。金山雲(03896.HK)及微盟(02013.HK)各升4.3%及3.9%,網易(09999.HK)、金蝶(00268.HK)、心動(02400.HK)及閱文(00772.HK)各升4.7%至5.5%,萬國數據(09698.HK)升8%。 據報今年內地春晚主會場確認與東方甄選合作,新東方在線(01797.HK)升15.2%。晶片設備股ASMPT(00522.HK)升9%。 金融股方面,匯控(00005.HK)升2.6%報55.5元,港交所(00388.HK)及友邦(01299.HK)各跌0.4%及0.5%。摩通升太保(02601.HK)評級至「增持」,目標價上調至24元,太保升5.5%。中國平安(02318.HK)升3.6%。 官媒指30家優質內房將獲支持改善負債,加大保交樓力度,內房股越秀地產(00123.HK)及富力(02777.HK)各升3%及3.1%。 醫藥股造好,藥明康德股東減持A股變現逾28億人民幣,藥明康德H股(02359.HK)仍升3.6%。同系藥明生物(02269.HK)升6.4%,高盛引述藥明生物管理層表示專注提升市場份額,指歐洲、日韓市場強勁增長。此外,金斯瑞(01548.HK)升9.5%,信達生物(01801.HK)、康希諾(06185.HK)及百濟神州(06160.HK)各升5.3%至6.2%。 波羅的海乾散貨指數跌逾6%失守千點,海豐國際(01308.HK)及太平洋航運(02343.HK)各跌4.5%及3.2%,近日遭瑞銀降評級至「中性」的招商局港口(00144.HK)今日股價跌5%。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account